Untargeted Metabolomic Profile for the Detection of Prostate Carcinoma—Preliminary Results from PARAFAC2 and PLS–DA Models

Prostate-specific antigen (PSA) is the main biomarker for the screening of prostate cancer (PCa), which has a high sensibility (higher than 80%) that is negatively offset by its poor specificity (only 30%, with the European cut-off of 4 ng/mL). This generates a large number of useless biopsies, invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Amante, Eleonora, Salomone, Alberto, Alladio, Eugenio, Vincenti, Marco, Porpiglia, Francesco, Bro, Rasmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749415/
https://www.ncbi.nlm.nih.gov/pubmed/31443574
http://dx.doi.org/10.3390/molecules24173063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749415/
https://www.ncbi.nlm.nih.gov/pubmed/31443574
http://dx.doi.org/10.3390/molecules24173063

Ejemplares similares